MeadowBrook Investment Advisors LLC Has $1.30 Million Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

MeadowBrook Investment Advisors LLC trimmed its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.2% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 14,424 shares of the exchange traded fund’s stock after selling 481 shares during the period. SPDR S&P Biotech ETF makes up about 1.1% of MeadowBrook Investment Advisors LLC’s holdings, making the stock its 22nd largest holding. MeadowBrook Investment Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $1,299,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Golden State Wealth Management LLC bought a new position in SPDR S&P Biotech ETF in the 4th quarter valued at about $29,000. Avior Wealth Management LLC raised its holdings in SPDR S&P Biotech ETF by 393.6% in the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after acquiring an additional 307 shares during the period. Tidemark LLC raised its holdings in SPDR S&P Biotech ETF by 101.5% in the 3rd quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock valued at $39,000 after acquiring an additional 199 shares during the period. Quintet Private Bank Europe S.A. bought a new position in SPDR S&P Biotech ETF in the 3rd quarter valued at about $40,000. Finally, ORG Wealth Partners LLC bought a new position in SPDR S&P Biotech ETF in the 3rd quarter valued at about $44,000.

SPDR S&P Biotech ETF Trading Down 1.4 %

Shares of XBI opened at $89.05 on Wednesday. SPDR S&P Biotech ETF has a 12 month low of $81.14 and a 12 month high of $105.47. The firm’s 50 day moving average is $92.23 and its 200-day moving average is $96.30. The stock has a market capitalization of $6.79 billion, a PE ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.